Jump to section
Lightship's mission is to redefine clinical trials, providing hope for all.
Clinical trials have historically been limited by factors like attendance and testing times. Turnaround can be slow, overheads can get costly, and those who don’t have the ability or time to meet appointments go unrepresented in medical developments. Lightship is hoping to redefine clinical trials with their end-to-end collaborative solution that offers at-home participation, making trials more accessible, and their results more representative.
With FDA regulations fairly recently updated to account for at-home trial participation, Lightship's arrival has been welcomed by the industry. The task of producing sound and accurate results outside of the lab is a tough one, so the company's efforts will certainly be valuable to this new clinical trial landscape.
Lightship is well-funded, and strategically partnered with eClinical platform Castor to accelerate its capabilities. With an increasing focus on making trial participants more diverse, and people now acclimatised to virtual engagement, its solution is promising and has the potential to yield vital clinical results.
Steph
Company Specialist at Welcome to the Jungle
Feb 2024
$135.6m
LATE VC
Oct 2021
$40m
LATE VC
This company has top investors
Samantha Eells
(Co-founder)Previously a Director at the Los Angeles Biomedical Research Institute, and COO and VP of Clinical Solutions at Science 37. Alongside this, held a position as Assistant Faculty Researcher at the University of California.
Alon Krashinsky
(Co-founder)CEO and Co-founder at Healthcare Foundry. Also co-founded Gather Health, Belong Health, House Rx and Trellis Rx.
Brian Lovett
(Co-founder)COO and Co-founder at Healthcare Foundry. Also co-founded Gather Health, Belong Health, House Rx and Trellis Rx.